About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials in Phoenix | 27 Studies

Clinical Trials SchizophreniaPhoenix

Schizophrenia Clinical Trials in Phoenix

Find 27 clinical trials for schizophrenia near Phoenix, Arizona. Connect with research centers in your area.

All Schizophrenia trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-27 of 27 trials

CompletedA Twelve Week, Open Label Extension Study in Patients With SchizophreniaThis is a 12-week, multi-center, open-label extension study designed to evaluate the longer-term safety, tolerability and effectiveness of lurasidone for the treatment of subjects…NCT01566162·Little Rock, Arkansas and 62 others

Schizophrenia Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedStudy Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To ZiprasidoneThe primary objective of this study is to evaluate change in weight as a result of switching from quetiapine to ziprasidone, in subjects with schizophrenia or schizoaffective…NCT00406315·Phoenix, Arizona and 39 others

Active not recruitingProposal To Develop A Rapid And Cost-Effective Diagnostic Test For SchizophreniaSchizophrenia is a severe psychotic illness of unknown cause that affects 1% of the population worldwide. Currently, there is no diagnostic test for schizophrenia.NCT03781115·Phoenix, Arizona

RecruitingSafety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum DisorderThis is a multicenter, global, 26-week, open-label study to assess the safety and tolerability of lumateperone in pediatric patients with schizophrenia, bipolar disorder or autism…NCT06229210·Phoenix, Arizona and 64 others

TerminatedThis Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 MonthsThe objective of the study is to investigate the efficacy, safety and tolerability of BI 409306 once daily compared with placebo given for 28 weeks in patients with schizophrenia…NCT03351244·Phoenix, Arizona and 58 others

CompletedEfficacy and Safety of Adjunctive Pimavanserin for the Treatment of Schizophrenia (ENHANCE-1)To evaluate the efficacy and safety of adjunctive pimavanserin compared with adjunctive placebo in the treatment of schizophreniaNCT02970292·Phoenix, Arizona and 104 others

RecruitingA Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and AdolescentsThe purpose of this study is to evaluate the long-term safety and tolerability of Xanomeline and Trospium Chloride for the treatment of psychiatric disorders in children and…NCT07424404·Dothan, Alabama and 93 others

PreviousPage 2 of 2

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia